文献速递其他结缔组织病

重叠ASyS与SjD患者ILD的临床与分子特征

Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该回顾性观察研究比较了131例ASyS、78例pSjD和42例ASyS-SjD患者,发现ASyS-SjD患者ILD起病更早、RP-ILD更多且肺功能较pSjD患者更差,但ILD特征与ASyS相当;转录组显示ASyS-SjD兼具ASyS的炎症和独特的促纤维化信号。

要点

  • ASyS-SjD患者ILD起病早于pSjD患者(10.0 vs 67.5个月,P<0.001)。
  • ASyS-SjD患者RP-ILD比例高于pSjD患者(16.7% vs 3.9%,P=0.015)。
  • ASyS-SjD患者肺功能较pSjD患者更差,ILD特征与ASyS相当。

核心结论

  • ASyS-SjD表现为ASyS样临床表型并附加促纤维化特征,提示可能为重叠亚型而非偶然共存。
  • ASyS-SjD的ILD较SjD更具侵袭性,但未明确比ASyS更严重。

研究设计与样本

  • 回顾性分析2020年6月至2023年6月南京医科大学第一附属医院131例ASyS、78例pSjD和42例ASyS-SjD患者。
  • 对8例ASyS、9例pSjD、10例ASyS-SjD患者及10例对照的外周血单个核细胞进行RNA测序。

主要发现

  • ASyS-SjD患者ILD起病时间早于pSjD患者(10.0 vs 67.5个月,P<0.001)。
  • ASyS-SjD患者RP-ILD比例高于pSjD患者(16.7% vs 3.9%,P=0.015)。
  • ASyS-SjD患者肺功能较pSjD患者更差:FEV1% 63.5% vs 76.6%(P=0.010)、FVC% 64.2% vs 77.0%(P=0.024)、DLCO% 60.7% vs 72.6%(P=0.046)。
  • ASyS-SjD患者HRCT以NSIP为主(75.6%),与ASyS相似,LIP罕见(2.4%)。
  • ASyS-SjD与ASyS的ILD特征相当;转录组显示ASyS-SjD共享ASyS的炎症并具有独特的促纤维化信号。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interstitial lung disease (ILD) is a frequent complication in both anti-synthetase syndrome (ASyS) and primary Sjögren's disease (pSjD), but the clinical and molecular phenotype of patients with overlapping ASyS and pSjD (ASyS-SjD) remains poorly defined. This study aimed to characterize the clinical, serological, radiological and transcriptomic features of ASyS-SjD patients with ILD, and to determine whether this overlap represents a distinct disease entity. METHODS: We retrospectively analysed 131 ASyS, 78 pSjD and 42 ASyS-SjD patients from the First Affiliated Hospital of Nanjing Medical University between June 2020 and June 2023. Clinical features, laboratory findings, pulmonary function and HRCT patterns were compared. RNA sequencing was performed on peripheral blood mononuclear cells from eight ASyS, nine pSjD, 10 ASyS-SjD patients and 10 controls. RESULTS: ASyS-SjD patients had earlier ILD onset (10.0 vs 67.5 months, P < 0.001), more RP-ILD (16.7% vs 3.9%, P = 0.015) and worse pulmonary function than pSjD patients (FEV1%: 63.5% vs 76.6%, P = 0.010; FVC%: 64.2% vs 77.0%, P = 0.024; DLCO%: 60.7% vs 72.6%, P = 0.046). HRCT showed predominantly NSIP in ASyS-SjD (75.6%), similar to ASyS, with rare LIP (2.4%). ILD characteristics between ASyS-SjD and ASyS were comparable. Transcriptomics revealed shared inflammation with ASyS plus unique profibrotic signalling in ASyS-SjD. CONCLUSION: ASyS-SjD exhibits an ASyS-like clinical phenotype with additional profibrotic features, suggesting it may represent an overlap subtype rather than a coincidental coexistence. While ILD in ASyS-SjD appears more aggressive than in SjD, it is not clearly more severe than in ASyS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Qiu Y, Lv C, Wang Y, et al. Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study. Rheumatology (Oxford). 2026. PMID: 41160481. doi:10.1093/rheumatology/keaf566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。